• No results found

Posttransplantation Lymphoproliferative Disease Treated by Retransplantation

N/A
N/A
Protected

Academic year: 2022

Share "Posttransplantation Lymphoproliferative Disease Treated by Retransplantation"

Copied!
4
0
0

Laster.... (Se fulltekst nå)

Fulltekst

Referanser

RELATERTE DOKUMENTER

Primary chronic cold agglutinin disease (CAD) is a well-defined clinicopathologic entity in which a bone marrow clonal B-cell lymphoproliferation results in autoimmune hemolytic

Healthy peripheral blood and bone marrow cells are stained with a pre-optimized “ backbone ” antibody panel in addi- tion to the progressively diluted (titrated) antibodies..

FigUre 1 | The effect of normal bone marrow mesenchymal stem cells (Mscs) on in vitro proliferation and viability of primary human acute myeloid leukemia (aMl) cells; a comparison

Light micrographs of human bone marrow mesenchymal stem cells (hBMSCs) exposed to tricalcium silicate cements (TSCs) [mineral trioxide aggregate (MTA), Biodentine, and TotalFill] for

The influence of autologous bone marrow stem cell transplantation on matrix metalloproteinases in patients treated for acute ST-elevation myocardial infarction..

Human bone marrow multipotent mesenchymal stromal cells (hBM-MSC) represent an appealing source of adult stem cells for cell therapy and tissue engineering.. Since hBM-MSC are

In 2014 we introduced anti-thymocyte globulin (ATG) to the graft-versus-host disease (GvHD) prophylaxis regimen in allogeneic stem cell transplantation (Allo-HSCT) with peripheral

Conclusion: In the present in vitro study, the isolated dental pulp cells expressed cell surface markers comparable to the expression from bone marrow mesenchymal stem cells